4Edwards BS, Zimmermann RS, Burnett JC Jr. Atrial natriuretic factor: physiologic action and implications in congestive heart failure.Cardiovasc Drugs Ther,1987, 1 : 89-100.
5Hunt PJ, Yandle TG, Nicholls MG, et al. The amino-terminal portion of pro-brain natriuretic peptide (pro-BNP) circulates in human plasma. Biochem Biophysl Res Commun, 1995, 214:1175-1183.
6Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive aminoterminal pro-brain natriuretie peptide (NT-PROBNP) : a new marker of cardiac impairment. Clin Endocrinol, 1997, 47 : 287-296.
7Sahn D J, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation of M-mode echecardiography: results of survey of echecardiography measurements. Circulation, 1978, 58 : 1072-1083.
8Vogeser M, Jacob K. B-type natriuretic peptide (BNP)--validation of an immediate response assay. Clin Lab, 2001, 47:29-33.
9Sayama H, Nakamura Y, Saito N, et al. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis. 1999. 10:537-540.
10Maeda K, Tsutamoto T, Wada A, et al. Plasma Brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure with symptomatic left ventricular dysfunction. Am. Heart J,1998, 135:825-832.
